Search results
Oct 28, 2019 · David Hung, M.D., has had a strange few years: From the man who led Medivation to being snapped up by Pfizer in a major $14 billion M&A deal, he then went over to Axovant, where it went very...
View David Hung, M.D.’s profile on LinkedIn, a professional community of 1 billion members. David is the founder, President and CEO of Nuvation Bio, a next-generation biotech company…
- 500+
- 4K
- Nuvation Bio
Jun 12, 2024 · T-Therapeutics appoints Dr David Hung as Chairman. Industry veteran, founder of Medivation and serial entrepreneur joins T-Therapeutics to support development of the company’s pipeline of...
Biopharma industry veteran, founder of Medivation and serial entrepreneur Dr David Hung has become chairman of Cambridge biotech start-up T-Therapeutics. He will support development of the company’s pipeline of TCR-based immuno-oncology drugs.
Jun 12, 2024 · T-Therapeutics appoints Dr David Hung as Chairman. Industry veteran, founder of Medivation and serial entrepreneur joins T-Therapeutics to support development of the company’s pipeline of...
Oct 28, 2019 · Nuvation’s CEO is Dr. David Hung. advertisement. For Hung, his leadership of the company marks a return to oncology and to the CEO seat. Hung is best known for founding Medivation — which...